Technology licensing
HUB offers licenses to its proprietary technology.
Source: LinkedIn company description · Retrieved October 13, 2026
HUB Organoids works in the field of adult stem cell-derived organoids.
HUB’s organoid technology is applied in drug discovery and development, preclinical patient stratification, predictive diagnostics, personalized medicine, clinical trials, regenerative medicine, and companion diagnostics.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
HUB offers licenses to its proprietary technology.
Source: LinkedIn company description · Retrieved October 13, 2026
HUB provides services its organoid biobank.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.